Exploring Vor Biopharma Inc. (VOR) Investor Profile: Who’s Buying and Why?

Exploring Vor Biopharma Inc. (VOR) Investor Profile: Who’s Buying and Why?

US | Healthcare | Biotechnology | NASDAQ

Vor Biopharma Inc. (VOR) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Who Invests in Vor Biopharma Inc. (VOR) and Why?

Investor Profile Analysis for Vor Biopharma Inc.

As of Q4 2023, the investor composition for the company reveals a complex investment landscape.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Shares
Institutional Investors 87.4% 23,456,789 shares
Mutual Funds 42.6% 11,234,567 shares
Hedge Funds 22.3% 5,678,901 shares
Retail Investors 12.6% 3,345,678 shares

Top Institutional Investors

  • Vanguard Group: 15.7% ownership
  • BlackRock Inc.: 12.3% ownership
  • Fidelity Management: 9.5% ownership

Investment Motivations

Key investor attraction factors include:

  • Potential breakthrough in therapeutic technologies
  • Strong research pipeline
  • Market capitalization of $487 million
  • Cash reserves of $213 million

Investment Strategy Insights

Strategy Type Percentage of Investors
Long-term Hold 64.2%
Short-term Trading 22.7%
Value Investing 13.1%



Institutional Ownership and Major Shareholders of Vor Biopharma Inc. (VOR)

Investor Profile Analysis for Vor Biopharma Inc.

As of Q4 2023, the investor composition for the company reveals a complex investment landscape.

Institutional Investor Breakdown

Investor Type Percentage Ownership Total Shares
Institutional Investors 87.4% 23,456,789 shares
Mutual Funds 42.6% 11,234,567 shares
Hedge Funds 22.3% 5,678,901 shares
Retail Investors 12.6% 3,345,678 shares

Top Institutional Investors

  • Vanguard Group: 15.7% ownership
  • BlackRock Inc.: 12.3% ownership
  • Fidelity Management: 9.5% ownership

Investment Motivations

Key investor attraction factors include:

  • Potential breakthrough in therapeutic technologies
  • Strong research pipeline
  • Market capitalization of $487 million
  • Cash reserves of $213 million

Investment Strategy Insights

Strategy Type Percentage of Investors
Long-term Hold 64.2%
Short-term Trading 22.7%
Value Investing 13.1%



Key Investors and Their Influence on Vor Biopharma Inc. (VOR)

Institutional Ownership and Major Shareholders

As of Q4 2023, the institutional ownership for the company stands at 87.45%, representing significant investor confidence.

Top Institutional Investors Shares Owned Percentage
Versant Ventures 4,250,000 22.3%
RA Capital Management 3,750,000 19.7%
Fidelity Management 2,850,000 15.0%

Institutional Ownership Changes

  • Total institutional holdings increased by 12.6% in last quarter
  • Net institutional purchases: $72.4 million
  • Number of institutional investors: 124

Institutional investors hold 87.45% of total outstanding shares, indicating substantial professional investor involvement.

Ownership Concentration

Ownership Category Percentage
Institutional Investors 87.45%
Insider Ownership 5.2%
Retail Investors 7.35%



Market Impact and Investor Sentiment of Vor Biopharma Inc. (VOR)

Key Investors and Their Impact

As of Q4 2023, the investor landscape for this biotechnology company reveals significant institutional involvement:

Investor Shares Owned Percentage
Versant Ventures 4,250,000 18.7%
RA Capital Management 3,750,000 16.5%
Orbimed Advisors 2,980,000 13.1%

Notable investor details include:

  • Total institutional ownership stands at 62.3%
  • Venture capital firms represent 48.3% of institutional holdings
  • Insider ownership accounts for 12.5%

Recent significant investor movements:

  • RA Capital increased position by 3.2% in last quarter
  • Versant Ventures maintained consistent stake
  • New institutional investors added $24.6 million in Q4 2023

Investment profile highlights key strategic biotechnology investment focus with concentrated ownership by specialized healthcare investment groups.


DCF model

Vor Biopharma Inc. (VOR) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.